Inform Genomics, Inc. - Product Pipeline Analysis - New Market Research Report
Inform Genomics, Inc. (Inform Genomics) is a development stage pharmaceutical company. The develops medicine products for cancer supportive care and inflammatory diseases. Its development stage products include OnPART, transplant test and InPART. The OnPART, Oncology Preferences And Risk of Toxicity, is used for treatment decisions in patients who receive chemotherapy for colorectal, breast, lung, or ovarian cancer. The transplant product is used to determine an individual patient's risk for developing oral and gastrointestinal mucositis due to high-dose chemotherapy regimens prior...
View full press release